DOC – Healthpeak Properties, Inc.

Healthpeak Properties, Inc. (DOC) Monthly Stock Report – December 07, 2025

Company Overview

Healthpeak Properties, Inc. is a prominent Real Estate Investment Trust (REIT) headquartered in Denver, Colorado. Established in 1985, the company focuses on the healthcare sector, managing a diversified portfolio that spans outpatient medical buildings, laboratory spaces, and Continuing Care Retirement Communities (CCRCs). Healthpeak operates through its self-administered subsidiary, Healthpeak OP, and currently holds interests in 703 properties. This includes 530 outpatient medical facilities and 139 laboratories, positioning Healthpeak as a key player in the U.S. healthcare real estate market. The company’s strong dedication to enhancing healthcare delivery underscores its operational viability and relevance in a crucial industry.

52-Week Price Performance Analysis

Healthpeak Properties, Inc. shares have demonstrated volatility over the past year, underscored by a 52-week high of $21.83 and a low of $16.63. Currently trading at $17.145, the stock is positioned slightly above its 52-week low, which implies a degree of support at this level.

Technical Analysis

The price chart reveals a predominantly bearish trend characterized by consistently lower highs and lower lows. A clear descending trendline establishes resistance, consistently pushing the stock lower when approaching this line. The key support level is found around $17.02, effectively acting as a floor that has halted more drastic declines, a reassuring sign for potential investors.

Conversely, resistance is evident in the $19-$20 range, where repeated attempts to breach this barrier have faltered, leading to sell-offs. The 50-day moving average, currently at $18.1934, further supports the argument for caution as the stock trades below this dynamic indicator, suggesting ongoing bearish momentum.

Overall, while the stock has recently shown signs of consolidation near its support level, investors should remain vigilant. A lack of decisive movement above the trendline or the moving average indicates that upward momentum may remain constrained.

Financial Performance and Metrics

Healthpeak Properties reported robust financial performance, with total revenues of approximately $2.8 billion. The company achieved an EBITDA of roughly $1.51 billion, reflecting significant operating profitability and solid financial stability.

• Market Capitalization: Approximately $11.9 billion (based on a share price of $17.145).
• Shares Outstanding: 694,949,823.
• Short Interest: 19,812,824 shares, translating to approximately 0.0378% of the float, indicating relatively low investor pessimism towards the stock.

Furthermore, with a dividend yield of 7.27%, Healthpeak has demonstrated commitment to returning value to shareholders, having paid dividends for 41 consecutive years. The quarterly cash dividend recently increased by 1.7% to $0.305 per share, reinforcing the company’s reliable income generation strategy.

Valuation Metrics

Healthpeak’s financial assessments indicate a favorable investment opportunity, marked by:
– Target High Price: $29.00
– Mean Target Price: $20.92
– Median Target Price: $20.00
– Recommendation Score: 1.9 (on a scale where 1 is a “strong buy”).

Given these positive metrics, there is a consensus among analysts that Healthpeak stocks present a compelling growth opportunity.

Recent News and Developments

Recent developments have shaped investor sentiment surrounding Healthpeak Properties:

1. 52-Week Low: On December 4, 2025, Healthpeak’s stock reached a 52-week low of $16.63, marking a 23.88% decline over the preceding year. This downturn underscores current market challenges, but the company’s strong dividend yield and consistent profit margins provide some reassurance. (Investing.com)

2. Earnings Report: In its Q4 2024 earnings, Healthpeak reported a slight net income per share increase to $0.01 and a 5.4% rise in cash net operating income. Strong leasing activity–an increase of 1.5 million square feet in new and renewal leases–demonstrates operational strength, particularly a 30% boost in lab lease renewals. (Investing.com)

3. Analyst Upgrades/Downgrades: In October 2024, Deutsche Bank upgraded Healthpeak’s rating from Hold to Buy, hinting at improved funds from operations estimates, while KeyBanc maintained a Sector Weight rating in July 2025 amidst concerns over lab occupancy rates. (Investing.com) (Investing.com)

Market Sentiment and Analyst Recommendations

The market sentiment surrounding Healthpeak Properties is cautiously optimistic, as reflected in the analyst consensus. With a mean recommendation score of 1.9, there is a strong inclination towards a buy rating, supported by substantial upside potential relative to the current stock price of $17.145.

• Price Targets:
• Target High Price: $29.00
• Average Target Price: $20.92
• Median Target Price: $20.00
• Lowest Target Price: $18.00

Despite current challenges, analysts believe the stock possesses an upside driven by the company’s robust operational fundamentals and appealing dividend yield.

Opportunities and Risks

While there is significant potential for growth, investors should also be mindful of inherent risks:
– Bearish Market Trends: The prevailing bearish sentiment, as observed in the stock’s pricing trend, may continue to influence investor decisions.
– Occupancy Concerns: The noted declines in lab occupancy could pose risks to future earnings growth and overall valuations.

In summary, Healthpeak Properties, Inc. represents a potentially lucrative investment for retail investors focusing on the healthcare real estate sector, provided they approach with equilibrium in mind, recognizing both the opportunities and risks presented in today’s market landscape.

Metric	Value
Market Cap	$11.9b
Total Debt	$9.4b
Total Cash	$98.8m
Shares Outstanding	694.9m
Float Shares	692.1m